| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.71T | 3.55T | 3.76T | 3.71T | 3.59T |
| Gross Profit | 1.32T | 1.17T | 1.16T | 1.14T | 1.12T |
| EBITDA | 381.87B | 445.80B | 370.73B | 557.97B | 446.38B |
| Net Income | 476.51B | 219.81B | 254.48B | 215.18B | 182.69B |
Balance Sheet | |||||
| Total Assets | 3.41T | 3.50T | 3.51T | 3.27T | 3.33T |
| Cash, Cash Equivalents and Short-Term Investments | 452.32B | 236.08B | 342.14B | 355.90B | 484.02B |
| Total Debt | 42.98B | 247.09B | 245.68B | 211.18B | 285.32B |
| Total Liabilities | 1.36T | 1.60T | 1.60T | 1.53T | 1.62T |
| Stockholders Equity | 2.03T | 1.74T | 1.75T | 1.59T | 1.59T |
Cash Flow | |||||
| Free Cash Flow | 242.97B | 142.98B | 113.38B | 52.23B | 105.10B |
| Operating Cash Flow | 358.52B | 303.88B | 309.22B | 220.33B | 248.35B |
| Investing Cash Flow | 149.29B | -89.18B | -157.24B | -42.81B | -59.27B |
| Financing Cash Flow | -398.74B | -240.45B | -181.49B | -313.58B | -193.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $110.40B | 17.31 | 24.82% | 2.25% | 7.27% | 0.49% | |
73 Outperform | $50.48B | 14.68 | 31.77% | 2.58% | 4.85% | 6.19% | |
72 Outperform | $33.95B | 12.08 | 25.02% | 0.54% | -0.54% | 112.21% | |
71 Outperform | $24.84B | 11.05 | 14.79% | 1.46% | 6.55% | -3.10% | |
66 Neutral | $22.15B | 15.72 | 15.03% | 2.78% | -0.55% | -3.97% | |
63 Neutral | $218.24B | 46.77 | 36.86% | 2.21% | 9.67% | 94.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |